SCHEMBL7987439

SCHEMBL7987439

CCc1nc(=O)c2c(ncn2Cc2ccc(C)cc2)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.43
PARN O95453 1/20 0.43
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
HTT P42858 1/20 0.40
BRD4 O60885 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
HPGD P15428 2/20 0.36
MAPK1 P28482 1/20 0.36
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989379 0.90 CNOT7 (0.41) CNOT7PARNLMNASMN1; SMN2TP53
SCHEMBL7988132 0.89 CNOT7 (0.44) CNOT7PARNLMNASMN1; SMN2BRD4
SCHEMBL7984530 0.89 HPGD (0.46) CNOT7PARNSMN1; SMN2CYP11B2HTT
SCHEMBL7975254 0.89 CNOT7 (0.55) CNOT7PARNSMN1; SMN2BRD4KMT2A
SCHEMBL7984380 0.89 CYP11B1 (0.40) CNOT7PARNLMNASMN1; SMN2MAPT
SCHEMBL7988039 0.88 CNOT7 (0.41) CNOT7PARNLMNASMN1; SMN2TP53
Hydrochloric Acid SCHEMBL7988145 0.87 CNOT7 (0.40) CNOT7PARNLMNASMN1; SMN2TP53
SCHEMBL7975139 0.87 CNOT7 (0.40) CNOT7PARNLMNASMN1; SMN2TP53
SCHEMBL7984470 0.87 ABCC8 (0.50) CNOT7PARNLMNASMN1; SMN2CYP11B1
SCHEMBL7973938 0.87 CNOT7 (0.48) CNOT7PARNSMN1; SMN2TP53CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed